tradingkey.logo
搜尋

Exicure Inc

XCUR
添加自選
1.600USD
+0.030+1.91%
收盤 07-31 16:00美東報價延遲15分鐘
10.20M總市值
虧損本益比TTM

關於 Exicure Inc 公司

Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.

Exicure Inc簡介

公司代碼XCUR
公司名稱Exicure Inc
上市日期May 09, 2018
CEOYoo (Andy)
員工數量7
證券類型Ordinary Share
年結日May 09
公司地址2430 N. Halsted St.
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編60614
電話18476731707
網址https://www.exicuretx.com/
公司代碼XCUR
上市日期May 09, 2018
CEOYoo (Andy)

Exicure Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--

常見問題

Exicure Inc的前五大股東是誰?

Exicure Inc的前五大股東如下:Mr. Dongho Lee
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有